Lurie et al. sought to investigate the differential genes that were associated with mesothelin expression in pancreatic ductal adenocarcinoma and found that there are multiple genes that had higher expression in the mesothelin-high group, including genes associated with poor prognosis, such as KCNN4, TNK3, and MUC1. This evidence concerns the gene MSLN and pancreatic ductal adenocarcinoma.